| Literature DB >> 20459679 |
Kerry A McBrien1, Ken P Kleinman, Allyson M Abrams, Lisa A Prosser.
Abstract
BACKGROUND: Syndromic surveillance systems can potentially be used to detect a bioterrorist attack earlier than traditional surveillance, by virtue of their near real-time analysis of relevant data. Receiver operator characteristic (ROC) curve analysis using the area under the curve (AUC) as a comparison metric has been recommended as a practical evaluation tool for syndromic surveillance systems, yet traditional ROC curves do not account for timeliness of detection or subsequent time-dependent health outcomes.Entities:
Mesh:
Year: 2010 PMID: 20459679 PMCID: PMC2876990 DOI: 10.1186/1472-6947-10-25
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Figure 1Decision model. Decision analytic model for a bioterrorist attack with bacillus anthracis.
Decision analytic model inputs
| Variable | Value | Range for sensitivity analysis | Source |
|---|---|---|---|
| Health state transition probabilities | |||
| Probability of recovery from fulminant anthrax | 0 | - | [ |
| Probability of recovery from prodromal anthrax | 0.857 | 0.66-0.9375 | [ |
| Probability of prophylactic antibiotic effectiveness | 1.0 | - | [ |
| Probability of developing mild side effects from antibiotics | 0.57 | 0.3-0.57 | [ |
| Probability of developing severe side effects from antibiotics | 0.003 | 0-0.01 | [ |
| Probability of seeking medical attention for mild side effects | 0.16 | 0-0.25 | [ |
| Probability of seeking medical attention for severe side effects | 1.0 | - | [ |
| Health state utility values | |||
| Death | 0 | - | |
| Recovery from anthrax | 0.56* | 0.4*-0.56† | [ |
| Mild side effects from antibiotics | 0.998 | 0.994-0.999 | [ |
| Severe side effects from antibiotics | 0.992 | 0.980-0.997 | [ |
| No side effects from antibiotics - healthy | 1.0 | - | |
| Cost estimates (2006 USD) | |||
| Cost of treatment of prodromal anthrax | 9,223 | 9223-18446‡ | [ |
| Cost of a course of prophylactic antibiotics | 638 | - | [ |
| Cost of office visit for mild side effects | 30 | - | [ |
| Cost of treatment of severe side effects | 189 | - | [ |
| Willingness to pay to avoid sequelae associated with recovery from anthrax | 214,910§ per year | Life*-5 yrs† | [ |
| Value of a statistical life | 7.3 m | 5.51 m-13.23 m | [ |
*This health state utility was matched to the EQ-5D [24], and assumed to continue throughout the life span. An average age of 36.5 years was assumed according to the US Census Bureau and average remaining life span of 43 years was calculated using the 2002 US Life Tables [25,26].
†A five year duration for this health state utility was used as the upper bound.
‡The upper bound was estimated by doubling the cost for the base case.
§This estimate was adjusted to assume that one out of every six anthrax patients would be able to return to work.
Figure 2AUC calculation methods. Weighted receiver operator characteristic curve for the generalized linear mixed effects model (GLMM 1) using lives-weighted sensitivity, depicting three methods for determining the area under the curve (AUC). From top to bottom: trapezoidal, rectangular, and truncated.
Figure 3Time dependent illness counts. Number predicted to have Anthrax disease by phase of illness and day of detection following a bioterrorist attack with bacillus anthracis.
Figure 4Time-dependent attack outcomes. Potential lives, quality adjusted life-years (QALYs), and costs saved by day of detection following a bioterrorist attack with bacillus anthracis.
AUC of weighted ROC curves - base case
| Lives - weighted | QALYs - weighted | Costs - weighted | |||||
|---|---|---|---|---|---|---|---|
| TS | 0.514 | TS | 0.448 | TS | 0.424 | TS | 0.65 |
| GLMM 1 | 0.447 | GLMM 1 | 0.411 | GLMM 1 | 0.397 | Scan 1 | 0.41 |
| Scan 1 | 0.431 | Scan 1 | 0.36 | GLMM 3 | 0.336 | Scan 3 | 0.378 |
| Scan 3 | 0.413 | GLMM 3 | 0.356 | Scan 1 | 0.333 | Scan 7 | 0.349 |
| GLMM 3 | 0.409 | Scan 3 | 0.34 | Scan 3 | 0.313 | GLMM 3 | 0.276 |
| Scan 7 | 0.377 | Scan 7 | 0.309 | Scan 7 | 0.283 | GLMM 7 | 0.271 |
| GLMM 7 | 0.316 | GLMM 7 | 0.269 | GLMM 7 | 0.251 | GLMM 1 | 0.235 |
Sensitivity analysis of AUC of weighted ROC curves - best case scenario
| Lives - weighted | QALYs - weighted | Costs - weighted | |||
|---|---|---|---|---|---|
| TS | 0.540 | TS | 0.499 | TS | 0.533 |
| Scan 1 | 0.470 | GLMM 1 | 0.432 | GLMM 1 | 0.469 |
| GLMM 1 | 0.468 | Scan 1 | 0.406 | Scan 1 | 0.469 |
| Scan 3 | 0.454 | GLMM 3 | 0.385 | Scan 3 | 0.455 |
| GLMM 3 | 0.438 | Scan 3 | 0.384 | GLMM 3 | 0.439 |
| Scan 7 | 0.413 | Scan 7 | 0.348 | Scan 7 | 0.415 |
| GLMM 7 | 0.339 | GLMM 7 | 0.293 | GLMM 7 | 0.340 |
Sensitivity analysis of AUC of weighted ROC curves - worst case scenario
| Lives - weighted | QALYs - weighted | Costs - weighted | |||
|---|---|---|---|---|---|
| TS | 0.467 | GLMM 1 | 0.375 | GLMM 1 | 0.329 |
| GLMM 1 | 0.434 | TS | 0.321 | GLMM 3 | 0.242 |
| Scan 1 | 0.400 | GLMM 3 | 0.306 | TS | 0.212 |
| Scan 3 | 0.391 | Scan 1 | 0.273 | Scan 1 | 0.178 |
| GLMM 3 | 0.385 | Scan 3 | 0.263 | Scan 3 | 0.170 |
| Scan 7 | 0.352 | Scan 7 | 0.240 | GLMM 7 | 0.168 |
| GLMM 7 | 0.300 | GLMM 7 | 0.225 | Scan 7 | 0.155 |
Sensitivity analysis of AUC of weighted ROC curves - 40% prophylaxis
| Lives - weighted | QALYs - weighted | Costs - weighted | |||
|---|---|---|---|---|---|
| TS | 0.514 | TS | 0.467 | TS | 0.449 |
| GLMM 1 | 0.447 | GLMM 1 | 0.415 | GLMM 1 | 0.403 |
| Scan 1 | 0.431 | Scan 1 | 0.371 | Scan 1 | 0.348 |
| Scan 3 | 0.413 | GLMM 3 | 0.363 | GLMM 3 | 0.345 |
| GLMM 3 | 0.409 | Scan 3 | 0.351 | Scan 3 | 0.327 |
| Scan 7 | 0.377 | Scan 7 | 0.318 | Scan 7 | 0.296 |
| GLMM 7 | 0.316 | GLMM 7 | 0.275 | GLMM 7 | 0.259 |
Sensitivity analysis of AUC of weighted ROC curves - rectangular calculation method
| Lives - weighted | QALYs - weighted | Costs - weighted | |||
|---|---|---|---|---|---|
| Scan 3 | 0.364 | Scan 3 | 0.297 | Scan 3 | 0.272 |
| Scan 7 | 0.347 | Scan 7 | 0.282 | Scan 7 | 0.258 |
| Scan 1 | 0.325 | Scan 1 | 0.267 | Scan 1 | 0.245 |
| GLMM 3 | 0.306 | TS | 0.254 | TS | 0.235 |
| TS | 0.303 | GLMM 3 | 0.248 | GLMM 3 | 0.227 |
| GLMM 1 | 0.260 | GLMM 1 | 0.213 | GLMM 1 | 0.195 |
| GLMM 7 | 0.246 | GLMM 7 | 0.199 | GLMM 7 | 0.182 |
Sensitivity analysis of AUC of weighted ROC curves - truncated method
| Lives - weighted | QALYs - weighted | Costs - weighted | |||
|---|---|---|---|---|---|
| Scan 3 | 0.205 | Scan 3 | 0.163 | Scan 3 | 0.148 |
| Scan 1 | 0.201 | Scan 1 | 0.162 | Scan 1 | 0.148 |
| Scan 7 | 0.171 | Scan 7 | 0.133 | Scan 7 | 0.119 |
| GLMM 3 | 0.104 | GLMM 3 | 0.082 | TS | 0.075 |
| TS | 0.097 | TS | 0.081 | GLMM 3 | 0.074 |
| GLMM 1 | 0.065 | GLMM 1 | 0.052 | GLMM 1 | 0.047 |
| GLMM 7 | 0.041 | GLMM 7 | 0.032 | GLMM 7 | 0.029 |